Advertisement

Topics

PercSys Company Profile

01:21 EDT 26th September 2017 | BioPortfolio

Approximately 1.7 million people in the U.S. experience kidney stones each year. Half of those will have at least one recurrence during their lifetime. One in four will find it necessary to undergo endoscopic lithotripsy (PCNL or ureteroscopic stone treatment). Once primarily a male affliction, kidney stone disease is increasingly affecting women, who now constitute two of every five cases diagnosed.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

PercSys

Approximately 1.7 million people in the U.S. experience kidney stones each year. Half of those will have at least one recurrence during their lifetime. One in four will find it necessary to undergo e...

More Information about "PercSys" on BioPortfolio

We have published hundreds of PercSys news stories on BioPortfolio along with dozens of PercSys Clinical Trials and PubMed Articles about PercSys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PercSys Companies in our database. You can also find out about relevant PercSys Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record